Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

QLT0267 stops hair follicle cell growth and movement.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Linagliptin slows down premature aging in certain mice.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

The FDA approved a new Pfizer drug for hair loss in teens.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Blocking mTORC1 reduces skin tumor growth in mice.

Letrozole may help prevent seizures by reducing certain hormone levels.

Ritlecitinib can help about 14,000 people with severe hair loss.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Erlotinib may cause scarring hair loss.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

CS12192 effectively treats alopecia areata with better safety than current options.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Bempikibart may help regrow hair in people with alopecia areata.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Sorafenib can cause a unique skin reaction.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.